Skip to main content
LBRX
NASDAQ Life Sciences

$150M Private Placement Fuels LB Pharma's Schizophrenia Trial Push

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$33.62
Mkt Cap
$1.002B
52W Low
$13.36
52W High
$38.625
52W Position info
152% above low
Off High info
13% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

LBRX has more than doubled off its 52-week low of $13.36.

Summary

LB Pharmaceuticals is raising $150 million through a private placement, a significant capital infusion for a company with a $1 billion market cap. The placement prices 3,577,560 shares at $34.94 and 715,513 pre-funded warrants at $34.9399, with gross proceeds of about $150 million and closing expected July 30, 2026. The funds arrive as enrollment in the pivotal Phase 3 NOVA-2 trial for schizophrenia drug LB-102 runs ahead of schedule, per the July 22 8-K. This follows the May initiation of the trial and the recent departure of the Chief Medical Officer. The raise extends the cash runway beyond the previously guided Q2 2029, de-risking the path to potential approval. Investor identity is not yet disclosed.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — The placement prices 3,577,560 shares at $34.94 and 715,513 pre-funded warrants at $34.9399, with gross proceeds of about $150 million and closing expected July 30, 2026.

At the time of this announcement, LBRX was trading at $33.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1B. The 52-week trading range was $13.36 to $38.63. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

LBRX - Latest Insights

LBRX
Nov 05, 2026, 8:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $38.09
Real-time Price: $38.09 info
Change: $0 (0%) info
Market Cap: $1.229B info
LBRX
Nov 05, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $38.09
Real-time Price: $38.09 info
Change: $0 (0%) info
Market Cap: $1.229B info
LBRX
Nov 05, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.09
Real-time Price: $38.09 info
Change: $0 (0%) info
Market Cap: $1.229B info
LBRX
Oct 01, 2026, 4:05 PM EDT
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $37.28
Real-time Price: $38.09 info
Change: +$0.810 (+2%) info
Market Cap: $1.229B info
LBRX
Aug 11, 2026, 8:10 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $46.76
Real-time Price: $38.09 info
Change: -$8.67 (-19%) info
Market Cap: $1.229B info